Any Signal provides end-to-end RF solutions for advanced aircraft, satellites, and national security, focusing on communications, radar, navigation, and RF sensing. Founded in 2022, the company aims to redefine RF capabilities by offering innovative, cost-effective solutions that integrate hardware, software modems, and supporting software for data management and telemetry. Their products are designed for the most demanding missions, addressing the shortcomings of existing solutions in terms of cost and innovation. With a commitment to harnessing cutting-edge technologies, Any Signal is positioned to lead in military and commercial RF applications.
Biofidelity developed a revolutionary molecular diagnostic assay that enables the rapid detection of target DNA sequences. Biofidelity’s mission is to improve and extend patients’ lives by enabling early detection of disease and better targeting of treatments with applications spanning oncology, prenatal testing, infectious disease, and organ transplant monitoring. Biofidelity was founded in 2019 and is headquartered of Cambridge, England.
bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines. Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable research and drug discovery teams to accelerate their experimental timelines and reduce experimental variability, providing an important alternative to traditional workflows. We are also leveraging our platform to build a pipeline of txCells for cell therapies. To achieve our goals, we have assembled a team of pioneers in stem cell biology, cell programming, mathematical modelling and cell therapy. We are empirical, highly ambitious and driven by a shared vision. Collaboration is at the heart of bit.bio. Join us on our journey.
Castelion is a venture-backed defense tech company applying modern hardware development and manufacturing processes to critical national security challenges, specifically to solve affordability, scale, and supply chain robustness.
Founded in 2017, Centrifuge creates better technology for financial products. Centrifuge provides asset managers a way to tokenize, manage and distribute their funds onchain and investors better access to a diversified portfolio of high-quality tokenized assets.
Corintis offers a game-changing solution to the cooling of next-generation high-performance GPUs, CPUs, and AI accelerators. It is developing silicon microfluidic cooling technologies that enable liquid coolant to flow in direct contact with the silicon chip.